{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T05:28:50Z","timestamp":1780723730352,"version":"3.54.1"},"reference-count":25,"publisher":"Medical Journals Sweden AB","license":[{"start":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T00:00:00Z","timestamp":1679961600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Derm Venereol"],"abstract":"<jats:p>Abstract is missing (Short communication)<\/jats:p>","DOI":"10.2340\/actadv.v103.4526","type":"journal-article","created":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T14:47:01Z","timestamp":1680014821000},"page":"adv4526","source":"Crossref","is-referenced-by-count":5,"title":["Dimethyl Fumarate Treatment in Patients with Moderate-to-Severe Psoriasis: A 52-week Real-life Study"],"prefix":"10.2340","volume":"103","author":[{"given":"Laura","family":"Gnesotto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Mioso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Bardazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Filippi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vito","family":"Di Lernia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberico","family":"Motolese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Di Nuzzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Conti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Arginelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Corazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Odorici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Borghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Gisondi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Naldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Dapavo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurora","family":"Parodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Burlando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Piaserico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1183","published-online":{"date-parts":[[2023,3,28]]},"reference":[{"key":"29695","doi-asserted-by":"crossref","unstructured":"Mrowietz U, Barker J, Boehncke WH, Iversen L, Kirby B, Naldi L, et al. Clinical use of dimethyl fumarate in moderate-to-severe plaque-type psoriasis: a European expert consensus. J Eur Acad Dermatol Venereol 2018; 32: 3-14.","DOI":"10.1111\/jdv.15218"},{"key":"29696","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/jdv.15218","DOI":"10.1111\/jdv.15218"},{"key":"29697","doi-asserted-by":"crossref","unstructured":"Malara G, Fabbrocini G, Trifir\u00f2 C, Burlando M. Dimethyl fumarate titration for the systemic treatment of moderate-to-severe plaque psoriasis. Drugs Context 2021; 10: 2020-12-4.","DOI":"10.7573\/dic.2020-12-4"},{"key":"29698","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.7573\/dic.2020-12-4","DOI":"10.7573\/dic.2020-12-4"},{"key":"29699","doi-asserted-by":"crossref","unstructured":"Lijnen R, Otters E, Balak D, Thio B. Long-term safety and effectiveness of high-dose dimethylfumarate in the treatment of moderate to severe psoriasis: a prospective single-blinded follow-up study. J Dermatolog Treat 2016; 27: 31-36.","DOI":"10.3109\/09546634.2015.1050980"},{"key":"29700","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.3109\/09546634.2015.1050980","DOI":"10.3109\/09546634.2015.1050980"},{"key":"29701","doi-asserted-by":"crossref","unstructured":"Corazza M, Odorici G, Conti A, Di Lernia V, Motolese A, Bardazzi F, et al. Dimethyl fumarate treatment for psoriasis in a real-life setting: a multicentric retrospective study. Dermatol Ther 2021; 34: 15066.","DOI":"10.1111\/dth.15066"},{"key":"29702","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/dth.15066","DOI":"10.1111\/dth.15066"},{"key":"29703","doi-asserted-by":"crossref","unstructured":"Esposito M, Campanati A, Giunta A, Calianno G, Bianchi L, Diotallevi F, et al. Dimethyl fumarate's effectiveness and safety in psoriasis: a real-life experience during the COVID-19 pandemic. Dermatol Ther (Heidelb) 2022; 12: 671-681.","DOI":"10.1007\/s13555-022-00684-3"},{"key":"29704","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1007\/s13555-022-00684-3","DOI":"10.1007\/s13555-022-00684-3"},{"key":"29705","doi-asserted-by":"crossref","unstructured":"Pezzolo E, Cazzaniga S, Di Leo S, Naldi L; PsoReal Study Group. Efficacy and safety of dimethyl fumarate in comparison with conventional therapy for psoriasis: an Italian real-world clinical experience. J Eur Acad Dermatol Venereol. 2022; 36: 534-537","DOI":"10.1111\/jdv.17997"},{"key":"29706","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/jdv.17997","DOI":"10.1111\/jdv.17997"},{"key":"29707","doi-asserted-by":"crossref","unstructured":"Hoefnagel JJ, Thio HB, Willemze R, Bouwes Bavinck JN. Long-term safety aspects of systemic therapy with fumaric acid esters in severe psoriasis. Br J Dermatol 2003; 149: 363-369.","DOI":"10.1046\/j.1365-2133.2003.05433.x"},{"key":"29708","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1046\/j.1365-2133.2003.05433.x","DOI":"10.1046\/j.1365-2133.2003.05433.x"},{"key":"29709","doi-asserted-by":"crossref","unstructured":"Walker F, Adamczyk A, Kellerer C, Belge K, Br\u00fcck J, Berner T, et al. Fumaderm\u00ae in daily practice for psoriasis: dosing, efficacy and quality of life. Br J Dermatol 2014; 171: 1197-205.","DOI":"10.1111\/bjd.13098"},{"key":"29710","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/bjd.13098","DOI":"10.1111\/bjd.13098"},{"key":"29711","doi-asserted-by":"crossref","unstructured":"Dickel H, Bruckner T, Altmeyer P. Long-term real-life safety profile and effectiveness of fumaric acid esters in psoriasis patients: a single-centre, retrospective, observational study. J Eur Acad Dermatol Venereol 2018; 32: 1710-1727.","DOI":"10.1111\/jdv.15019"},{"key":"29712","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/jdv.15019","DOI":"10.1111\/jdv.15019"},{"key":"29713","doi-asserted-by":"crossref","unstructured":"Mrowietz U, Sorbe C, Reich K, Von Kiedrowski R, Weckbecker J, Radtke MA, et al. Fumaric acid esters for the treatment of psoriasis in Germany: characterising patients in routine care. Eur J Dermatol 2020; 30: 41-48.","DOI":"10.1684\/ejd.2020.3709"},{"key":"29714","doi-asserted-by":"crossref","unstructured":"Termeer C, Reinhold U, Dirschka T, von Kiedrowski R, Kurzen H. Long-term use of fumaric acid esters for the treatment of psoriasis in daily practice. J Dermatolog Treat 2021; 32: 610-616.","DOI":"10.1080\/09546634.2019.1688234"},{"key":"29715","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1080\/09546634.2019.1688234","DOI":"10.1080\/09546634.2019.1688234"},{"key":"29716","doi-asserted-by":"crossref","unstructured":"Ricceri F, Bardazzi F, Buggiani G, Burlando M, Campione E, Corazza M, et al. Efficacy and safety of dimethylfumarate in elderly psoriasis patients: a multicentric Italian study. J Dermatolog Treat 2021; 11: 1-4.","DOI":"10.1080\/09546634.2021.1962000"},{"key":"29717","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1080\/09546634.2021.1962000","DOI":"10.1080\/09546634.2021.1962000"},{"key":"29718","doi-asserted-by":"crossref","unstructured":"Mrowietz U, Szepietowski JC, Loewe R, van de Kerkhof P, Lamarca R, Ocker WG, et al. Efficacy and safety of LAS41008 (dimethyl fumarate) in adults with moderate-to-severe chronic plaque psoriasis: a randomized, double-blind, Fumaderm\u00ae-and placebo-controlled trial (BRIDGE). Br J Dermatol 2017; 176: 615-623.","DOI":"10.1111\/bjd.14947"},{"key":"29719","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/bjd.14947","DOI":"10.1111\/bjd.14947"}],"container-title":["Acta Dermato-Venereologica"],"original-title":[],"link":[{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/4526\/15679","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/4526\/15679","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,9]],"date-time":"2023-12-09T20:22:17Z","timestamp":1702153337000},"score":1,"resource":{"primary":{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/view\/4526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,28]]},"references-count":25,"URL":"https:\/\/doi.org\/10.2340\/actadv.v103.4526","relation":{},"ISSN":["1651-2057","0001-5555"],"issn-type":[{"value":"1651-2057","type":"electronic"},{"value":"0001-5555","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3,28]]}}}